![Quiver Logo](/static/img/logo-icon.png)
![SILO logo](https://quiver-logos.s3.us-east-2.amazonaws.com/silo.png)
Silo Pharma, Inc. Common Stock
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view SILO Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of SILO by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by SILO's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to SILO
Recent picks made for SILO stock on CNBC
ETFs with the largest estimated holdings in SILO
Flights by private jets registered to SILO
![Quiver Logo](/static/img/logo-icon.png)